Please assess the completion status of the following clinical trial:

Trial Title: The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients 18 years old or older~* patients who signed informed consent~* patients with dilated cardiomyopathy (according ESC 2007)~* patients who had no significant coronary artery stenoses \>30% on cardiac catheterization~Exclusion Criteria:~* BP ≥140/90 lub \<90/60~* congenital heart disease~* acquired valvular disease except for mitral incompetence secondary to left ventricular dilatation~* New York Heart Association (NYHA) functional class IV~* statin treatment~* preserved hyperactivity of aminotransferases with unexplained etiology,~* muscle disorders which might cause drug-induced myopathy,~* uncontrolled diabetes,~* liver diseases,~* creatinine level \> 2 mg/dl and/or GFR\<30ml/min,~* abuse of alcohol or drugs,~* chronic inflammatory diseases,~* pregnancy or lactation,~* severe hypothyroidism,~* immunosuppressive treatment,~* operation or severe injury during last month~* vaccination during last 3 months~* heart stimulation device or implantable cardioverter defibrillator~* or who didn't write conscious consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: None): None
- No statin (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).